Abstract:Background: Ischemic stroke is a leading cause of mortality and long-term disability globally. Current recanalization therapies, including mechanical thrombectomy and thrombolysis, aim to restore blood flow in acute ischemic stroke patients. However, many patients with successful recanalization still experience poor clinical outcomes. This phenomenon, where the restoration of blood flow does not translate into functional recovery, is known as futile recanalization. Methods: Using a murine middle cerebral occlusion (MCAO) model that mimics a large vessel occlusion with recanalization, a comprehensive microarray analysis of gene expression from blood samples collected during MCAO and after recanalization (N=44) was performed. Results: Il1r2, Cd55, Mmp8, Cd14, and Cd69 were key regulatory genes expressed early after MCAO and recanalization. A comparison with gene expression data from human stroke patients and rat MCAO model (GSE16561 and GSE21136) revealed Vcan as a differentially expressed gene conserved across species, marking it as a novel indicator of recanalization that was detected as early as 3 hours post-recanalization (4 hours post-MCAO) in mice and 24 hours after recanalization in rats (MCAO-thrombectomy) and humans (rtPA-thrombolysis). Leukocyte and neutrophil activation pathways were significantly enriched in the mouse data and human samples from GSE16561, with greater upregulation in female subjects. The analysis identified key miRNAs regulating gene expression in response to recanalization, and NFE4 and MTF1 as crucial transcription factors regulating these processes. Based on these data, a coregulatory network underlying neutrophil activity was constructed, highlighting its central role in early recanalization responses, especially in females. Conclusions: This study identified new genomic markers in blood associated with recanalization, and identified critical age- and sex-specific factors. By mapping a coregulatory network of interacting genes and neutrophil-related pathways, the data provides insights to inform future research and develop targeted therapies. Such therapies can improve recanalization efficacy or modulate leukocytes to reduce futile recanalization, ultimately enhancing clinical outcomes for ischemic stroke patients.

Decoding Molecular Mechanisms Underlying Outcomes After Ischemic Stroke Thrombectomy by RNA Sequencing of Retrieved Clots

Abstract 162: Arterial Aspirate Derived Exosomes From Patients With Large Vessel Occlusion Are Associated With Increased Blood-brain Barrier Permeability, Decreased Endothelial Integrity As Well Poor Clinical And Radiographic Outcomes Following Mechanical Thrombectomy

Abstract 102: Microanatomy of Intracranial Human Thrombi by Single Nuclei Transcriptomics

Gene expression profiles of ischemic stroke clots retrieved by mechanical thrombectomy are associated with disease etiology

Utilizing RNA sequencing to identify gene expression markers of stroke-causing thrombi origin: A pilot study

Molecular Profiling of the Stroke-Induced Alterations in the Cerebral Microvasculature Reveals Promising Therapeutic Candidates.

Abstract 147: Novel Inflammatory and Pro-Thrombotic mRNA Pathways Associated With Worse 3-month Outcome After Intracerebral Hemorrhage

Bioinformatic Exploration of Circulating microRNAs Related to Functional Outcomes in Patients With Acute Ischemic Stroke: An Exploratory Prospective Study

Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans.

Early transcriptional changes in neutrophil-mediated processes following recanalization after ischemic stroke

Improving Stroke Outcome Prediction Using Molecular and Machine Learning Approaches in Large Vessel Occlusion

Histologically interpretable clot radiomic features predict treatment outcomes of mechanical thrombectomy for ischemic stroke

Abstract WP304: Investigating Thrombus Architecture Using Spatial Transcriptomics

Non-coding RNAs in stroke pathology, diagnostics, and therapeutics

Monocyte, Neutrophil, and Whole Blood Transcriptome Dynamics Following Ischemic Stroke.

Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke

Single-cell RNA sequencing in stroke and traumatic brain injury: Current achievements, challenges, and future perspectives on transcriptomic profiling

Unveiling the Therapeutic Potential of Non-Coding RNAs in Stroke-Induced Tissue Regeneration

Non-Coding RNA in Acute Ischemic Stroke: Mechanisms, Biomarkers and Therapeutic Targets.

Abstract 2948: Ischemic Transient Neurological Events Identified by Immune Response to Cerebral Ischemia

Translationally relevant transcriptomic alterations in mouse ischemic cerebral microvessels